DATATRAK ONE® Enters Preclinical Trials Extending Leadership Across All Trial Phases
Texas A&M Institute for Preclinical Studies (TIPS) enters Agreement
CLEVELAND, Feb. 4, 2014 /PRNewswire/ — DATATRAK International, Inc. (OTCQX: DTRK), a leader in cloud-based, unified eClinical® technologies and related services for the clinical trials industry, today announced Texas A&M Institute for Preclinical Studies (TIPS) will utilize the DATATRAK ONE® software suite.
TIPS, a unit within the Texas A&M College of Veterinary Medicine & Biomedical Sciences, provides a unique resource serving the preclinical needs of academic researchers and leaders in the biomedical and pharmaceutical industry. Texas A&M has a longstanding reputation as a leader in higher education and research, with the College of Veterinary Medicine & Biomedical Sciences being one of the largest veterinary schools in the United States, and having a wealth of expertise in:
-- All major veterinary medical specialties -- Surgical and non-surgical interventional techniques -- Advanced imaging and diagnostics
“We have found DATATRAK to be extremely easy to work with, and we look forward to using the technology to meet our needs,” said Dr. Matt Miller, director of TIPS. “Collaborating with DATATRAK will prove beneficial, as we continue to serve our Texas A&M University researchers, as well as the research and development enterprise within the biomedical and pharmaceutical industry.”
“The efficiencies of DATATRAK ONE® are impactful to every phase of the trial process,” stated Laurence P. Birch, DATATRAK Chairman of the Board and CEO. “TAMU is a leading veterinary medicine institution and the ideal partner for DATATRAK as we extend our expertise to academic research. From preclinical to post-approval, cost and time savings are realized leveraging our truly unified system to optimize each trial, across all phases, from Concept to Cure®.”
Join DATATRAK Thought Leaders:
-- Twitter -- LinkedIn -- SlideShare -- The DATATRAK Blog
Tweet: . @tamuvetmed partners with #DATATRAK ONE® in #preclinical studies extending #EDC leadership http://bit.ly/1fq0e9r
DATATRAK International is a worldwide technology and services company delivering unified eClinical® solutions and related services for the clinical trials industry. DATATRAK built its multi-component, comprehensive solution on a single, unified platform and expanded this concept to include services delivery via DATATRAK‘s Clinical and Consulting Services group. The Company delivers a complete portfolio of software products designed to accelerate the reporting of clinical research data from sites to sponsors and ultimately regulatory authorities, faster and more efficiently than loosely integrated technologies. The DATATRAKONE® software solution, deployed worldwide through an ASP or Enterprise Transfer offering, supports Phase I – Phase IV drug and device studies in multiple languages throughout the world. DATATRAK has offices located in Cleveland, Ohio; Bryan, Texas; and Cary (RTP), North Carolina.
Contact DATATRAK at email@example.com, follow the discussion on Twitter at @DATATRAKInc, join us on LinkedIn for industry insights and visit http://www.datatrak.com to find out more about how DATATRAK one optimizes the eClinical data process.
Except for the historical information contained in this press release, the statements made in this release are forward-looking statements. These forward-looking statements are made based on management’s expectations, assumptions, estimates and current beliefs concerning the operations, future results and prospects of the Company and are subject to uncertainties and factors which are difficult to predict and, in many instances, are beyond the control of the Company, and which could cause actual results to differ materially from those contemplated in these forward-looking statements. For a list of certain factors that may cause actual results to differ materially from those contemplated in these forward looking statements, please see the Company’s report filed with the OTCQX Market on November 13, 2013 announcing its results for the third quarter of 2013. The Company undertakes no obligation to update publicly or revise any forward-looking statement whether as a result of new information, future events or otherwise.
SOURCE DATATRAK International, Inc.